Genexine
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
About
Technology stack
detected 2026-06-25No comments yet. Be the first to share your take.
What does Genexine do?
Genexine is a biopharmaceutical company dedicated to developing innovative biologics to address serious health issues and improve patient lives. They focus on creating novel immunotherapies for cancer and antibody therapies for rare diseases, utilizing proprietary platforms like the long-acting hyFc® Fusion Platform and DNA Vaccine Platform. Their pipeline includes treatments for anemia, growth hormone deficiency, and cervical cancer, aiming to save lives through scientific innovation.
How much funding has Genexine raised?
Genexine has raised a total of $297M in funding. The most recent round on record is Funding.
Where is Genexine headquartered?
Genexine is headquartered in Seoul, South Korea.
When was Genexine founded?
Genexine was founded in 1999.
What industry does Genexine operate in?
Genexine operates in Biotechnology, HealthTech, Drug Discovery, Immunotherapy, Oncology, Rare Diseases.